In hepatocellular carcinoma (HCC), high GRAMD1A expression is associated with poor prognosis, and it has been shown to promote the self-renewal of liver cancer stem cells and drive hepatocarcinogenesis through the upregulation of STAT5 (32). Here, GRAMD1A is linked to hepatocellular carcinoma.